Is This Dividend Pharma Stock Going Against the Grain?

Despite losing patent protection for its blockbuster drug, Singulair, over the summer, pharma giant Merck's (NYSE: MRK  ) shares have appreciated 18% year to date, and the company has a slew of therapeutics in development. In addition, while some of the biggest players in the health care space -- including Pfizer  (NYSE: PFE  )  and Abbott  (NYSE: ABT  )  -- are spinning-out businesses, Merck doesn't look like it will be following suit.

In the following video, health care analysts Max Macaluso and Brenton Flynn discuss Merck's current strategy and give a helpful overview of the company's main growth drivers.

With the impending spinoff of its branded-drug business, Abbott Labs is losing a massive blockbuster drug in Humira. It's a confusing event to understand, with many investors left wondering what to do with these two stocks once they're separated. To help investors better understand the upcoming event, the Fool has created a brand new premium report outlining both Abbott Labs and its spinoff, AbbVie. Inside, we outline all of the must-know opportunities and risks facing both companies, so make sure to claim this 2-for-1 report by clicking here now

Read/Post Comments (0) | Recommend This Article (1)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2133015, ~/Articles/ArticleHandler.aspx, 10/24/2016 10:40:30 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,228.37 82.66 0.46%
S&P 500 2,150.64 9.48 0.44%
NASD 5,303.78 46.37 0.88%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

10/24/2016 10:24 AM
MRK $61.20 Down -0.01 -0.01%
Merck and Co. CAPS Rating: ****
ABT $40.67 Up +0.17 +0.41%
Abbott Laboratorie… CAPS Rating: *****
AZN $30.11 Down -0.61 -1.99%
AstraZeneca CAPS Rating: ****
BMY $49.65 Down -0.37 -0.74%
Bristol-Myers Squi… CAPS Rating: ****
PFE $32.27 Up +0.09 +0.26%
Pfizer CAPS Rating: ****